Your browser doesn't support javascript.
loading
The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers.
Eissa, Ibrahim Ragab; Bustos-Villalobos, Itzel; Ichinose, Toru; Matsumura, Shigeru; Naoe, Yoshinori; Miyajima, Noriyuki; Morimoto, Daishi; Mukoyama, Nobuaki; Zhiwen, Wu; Tanaka, Maki; Hasegawa, Hitoki; Sumigama, Seiji; Aleksic, Branko; Kodera, Yasuhiro; Kasuya, Hideki.
Afiliação
  • Eissa IR; Cancer Immune Therapy Research Center, Graduate School of Medicine, Nagoya University, Nagoya 466-8550, Japan. brahimessa@med.nagoya-u.ac.jp.
  • Bustos-Villalobos I; Department of Surgery II, Graduate School of Medicine, Nagoya University, Nagoya 466-8550, Japan. brahimessa@med.nagoya-u.ac.jp.
  • Ichinose T; Faculty of Science, Tanta University, Tanta 31527, Egypt. brahimessa@med.nagoya-u.ac.jp.
  • Matsumura S; Cancer Immune Therapy Research Center, Graduate School of Medicine, Nagoya University, Nagoya 466-8550, Japan. bustositzel@med.nagoya-u.ac.jp.
  • Naoe Y; Cancer Immune Therapy Research Center, Graduate School of Medicine, Nagoya University, Nagoya 466-8550, Japan. t-ichinose@med.nagoya-u.ac.jp.
  • Miyajima N; Cancer Immune Therapy Research Center, Graduate School of Medicine, Nagoya University, Nagoya 466-8550, Japan. smatsumu@med.nagoya-u.ac.jp.
  • Morimoto D; Cancer Immune Therapy Research Center, Graduate School of Medicine, Nagoya University, Nagoya 466-8550, Japan. ynaoe@med.nagoya-u.ac.jp.
  • Mukoyama N; Department of Transplantation and Endocrine Surgery, Graduate School of Medicine, Nagoya University, Nagoya 466-8550, Japan. miyajima@med.nagoya-u.ac.jp.
  • Zhiwen W; Department of Surgery II, Graduate School of Medicine, Nagoya University, Nagoya 466-8550, Japan. d-morimoto@med.nagoya-u.ac.jp.
  • Tanaka M; Department of Otolaryngology Graduate School of Medicine, Nagoya University, Nagoya 466-8550, Japan. tamgpad7042@gmail.com.
  • Hasegawa H; Cancer Immune Therapy Research Center, Graduate School of Medicine, Nagoya University, Nagoya 466-8550, Japan. wu.zhiwen@med.nagoya-u.ac.jp.
  • Sumigama S; Department of Surgery II, Graduate School of Medicine, Nagoya University, Nagoya 466-8550, Japan. wu.zhiwen@med.nagoya-u.ac.jp.
  • Aleksic B; Takara Bio Inc., Kusatsu, Shiga 525-0028, Japan. tanakamy@takara-bio.co.jp.
  • Kodera Y; Office of International Affairs, Graduate School of Medicine, Nagoya University, Nagoya 466-8550, Japan. hitoki@med.nagoya-u.ac.jp.
  • Kasuya H; Office of International Affairs, Graduate School of Medicine, Nagoya University, Nagoya 466-8550, Japan. sumigama@med.nagoya-u.ac.jp.
Cancers (Basel) ; 10(10)2018 Sep 26.
Article em En | MEDLINE | ID: mdl-30261620

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article